PESERICO STECCHINI NEGRI DE SALVI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.496
AS - Asia 9.129
EU - Europa 4.296
AF - Africa 1.737
SA - Sud America 1.509
Continente sconosciuto - Info sul continente non disponibili 227
OC - Oceania 193
Totale 34.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.577
SG - Singapore 2.872
CN - Cina 1.359
VN - Vietnam 1.192
HK - Hong Kong 999
BR - Brasile 836
IT - Italia 507
FI - Finlandia 418
DE - Germania 408
FR - Francia 367
BD - Bangladesh 340
UA - Ucraina 336
SE - Svezia 288
IN - India 284
PL - Polonia 254
GB - Regno Unito 169
IQ - Iraq 168
RU - Federazione Russa 158
TR - Turchia 140
AR - Argentina 130
PH - Filippine 121
JP - Giappone 115
PK - Pakistan 113
SA - Arabia Saudita 97
MX - Messico 94
ID - Indonesia 88
CO - Colombia 86
UZ - Uzbekistan 84
NL - Olanda 82
EC - Ecuador 80
ZA - Sudafrica 77
CA - Canada 73
IE - Irlanda 73
MA - Marocco 71
VE - Venezuela 71
MY - Malesia 70
ES - Italia 69
NP - Nepal 68
AT - Austria 67
BJ - Benin 64
EG - Egitto 63
JO - Giordania 63
CL - Cile 62
PE - Perù 61
TH - Thailandia 61
JM - Giamaica 60
KE - Kenya 59
IL - Israele 58
RS - Serbia 56
AU - Australia 54
MK - Macedonia 54
RO - Romania 54
AL - Albania 53
NI - Nicaragua 53
AO - Angola 51
HN - Honduras 51
LY - Libia 51
TN - Tunisia 51
AE - Emirati Arabi Uniti 50
BG - Bulgaria 50
KZ - Kazakistan 50
PT - Portogallo 50
UY - Uruguay 50
AZ - Azerbaigian 49
ET - Etiopia 49
MD - Moldavia 49
ME - Montenegro 49
YT - Mayotte 49
BE - Belgio 48
CH - Svizzera 48
LB - Libano 48
LU - Lussemburgo 48
BB - Barbados 47
BO - Bolivia 47
CW - ???statistics.table.value.countryCode.CW??? 47
GR - Grecia 47
KR - Corea 47
TJ - Tagikistan 47
ZW - Zimbabwe 47
BZ - Belize 46
CI - Costa d'Avorio 46
IR - Iran 46
IS - Islanda 46
LA - Repubblica Popolare Democratica del Laos 46
MU - Mauritius 46
MR - Mauritania 45
GF - Guiana Francese 44
HU - Ungheria 44
ML - Mali 44
SI - Slovenia 44
XK - ???statistics.table.value.countryCode.XK??? 44
BS - Bahamas 43
DO - Repubblica Dominicana 43
PA - Panama 43
UG - Uganda 43
CU - Cuba 42
KG - Kirghizistan 42
SO - Somalia 42
GE - Georgia 41
GN - Guinea 41
Totale 32.417
Salva come PNG Salva come JPEG
Città #
Fairfield 2.016
Singapore 1.635
Ashburn 1.357
San Jose 1.347
Woodbridge 1.247
Jacksonville 1.211
Houston 961
Hong Kong 911
Chandler 854
Ann Arbor 794
Wilmington 745
Seattle 740
Cambridge 692
Princeton 493
Boardman 365
Ho Chi Minh City 355
Hanoi 302
Los Angeles 241
Beijing 226
San Diego 210
Santa Clara 203
Lauterbourg 192
Bytom 172
Helsinki 161
Nanjing 124
Roxbury 112
Council Bluffs 99
Medford 94
Des Moines 90
New York 89
São Paulo 78
Tashkent 77
Da Nang 71
Baghdad 64
Chicago 62
Amman 61
Cotonou 61
Tokyo 61
Guangzhou 60
Haiphong 58
Dublin 56
Managua 51
Milan 49
Nairobi 47
Baku 46
Hebei 46
Vienna 46
Dushanbe 45
Montevideo 45
Abidjan 44
Dong Ket 44
Nouakchott 44
Bridgetown 43
Harare 43
Kampala 43
Luanda 43
Padova 43
Addis Ababa 41
Bamako 41
Dakar 41
Nassau 41
Conakry 40
Podgorica 40
Redwood City 40
Vientiane 40
Jeddah 39
Panama City 39
Shenyang 39
Kingston 38
Kigali 37
Kuala Lumpur 37
London 37
Ulan Bator 37
Havana 36
Warsaw 36
Cayenne 35
Reykjavik 35
Rome 35
Tianjin 35
Bishkek 34
Istanbul 34
Libreville 34
Lusaka 34
Quito 34
Riga 34
Willemstad 34
Yerevan 34
Buffalo 33
Lima 33
Munich 33
Norwalk 33
Nanchang 32
Noumea 32
Phnom Penh 32
Accra 31
Lahore 31
Pristina 31
Antananarivo 30
Johannesburg 30
Mamoudzou 30
Totale 20.991
Salva come PNG Salva come JPEG
Nome #
Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. 382
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 376
Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis 300
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. 278
Effectiveness of different substrate materials for in vitro sunscreen tests 272
Assessing the Impact of Atopic Dermatitis on the Patients' Parents with the Visual Instrument ‘Caregiver-PRISM' 272
Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy 271
Abnormal total ejection isovolume index as early noninvasive marker of chronic rejection in heart transplantation 261
Early macular retinal ganglion cell loss in dominant optic atrophy: Genotype-phenotype correlation 256
Symmetrical, hypopigmented papules and plaques on the palms induced by contact with water: A quiz 252
Contact Sensitization in Children: A Retrospective Study of 2,614 Children from a Single Center 241
Generalized granuloma annulare treated with methylaminolevulinate photodynamic therapy 224
High rejection score in the first year and risk of skin cancer in heart transplantation 220
Skin cancer and other cutaneous disorders in liver transplant recipients. 213
Psoriasis - The Life Course Approach 210
Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and literature rewiew 209
Patch test results with fragrance markers of the baseline series - Analysis of the European Surveillance System on Contact Allergies (ESSCA) network 2009-2012 209
Patch test results with the European baseline series and additions thereof in the {ESSCA} network, 2015-2018 207
Erythroderma in the era of biological therapies. 204
Absent or low expression of T-cell receptor zeta-chain in T-cells infiltrating human pathological skin conditions 204
Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosuppressive load 203
Variability in human and automatic segmentation of melanocytic lesions. 203
Early detection of melanoma: an educational campaign in Padova, Italy. 202
Skin disorders in patients transplanted in childhood 201
Impaired coronary flow reserve in young patients affected by severe psoriasis 200
Life events and alopecia areata. 197
Efficacy of Biofeedback and Cognitive-behavioural Therapy in Psoriatic PatientsA Single-blind, Randomized and Controlled Study with Added Narrow-band Ultraviolet B Therapy 197
Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study 193
Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: Four illustrative cases 193
De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis 192
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. 191
TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going? 189
Dermoscopic Changes in Melanocytic Naevi in Children during Digital Follow-up. 187
Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study 187
Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe-analyses of the European Surveillance System on Contact Allergy network, 2002-2010 184
Cutaneous viral infections in organ transplant patients 182
In situ expression of LAT (linker for activation of T cells) in pathological human skin with T-lymphoid infiltrate 181
Variability in human and automatic localization of melanocytic lesions 181
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study 181
Sex hormone-binding globulin and saliva testosterone levels in men with androgenetic alopecia 180
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 180
[Arterial hypertension and the renin-angiotensin-aldosterone system in psoriasis] 179
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study 179
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry. 179
Non-alcoholic fatty liver disease, alcohol intake and psoriasis 178
Efficacy, tolerability and safety of switching from etanercept to infliximab for the treatment of moderate-to-severe psoriasis: A multicenter, open-label trial (TANGO) 178
CD30+ lymphoproliferative disorders of the skin: still an open question 177
High dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T -cell lymphoma 176
ANTICARDIOLIPIN ANTIBODIES AND ANTIPHOSPHOLIPID SYNDROME IN CHRONIC DISCOID LUPUS-ERYTHEMATOSUS 176
Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel. 176
Kobner phenomenon in psoriasis induced by Mantoux test 175
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up 175
Incidence and significance of organ-specific autoimmune disorders (clinical, latent or autoantibodies) in patients with vitiligo 174
Squamous cell carcinoma. 174
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: An analysis based on Italian actual clinical practice 172
Medical history, drug exposure and the risk of psoriasis 171
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. 171
Immunoglobulin heavy chain variable region family expression in primary cutaneous follicle centre cell lymphomas 171
Sensitivity of cultured lymphocytes from patients with nevoid basal cell carcinoma syndrome to ultraviolet light and phytohemagglutinin stimulation 170
Prevalence of polycystic ovaries in women with acne 169
Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy 168
[Eye manifestations in vitiligo] 166
Circulating antibodies in malignant melanoma patients. 166
High rejection score in the first year and risk of skin cancer in heart transplantation 165
Autoantibodies in vitiligo 164
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study 164
Diaminodiphenylmethane (DDM): frequency of sensitization, clinical relevance and concomitant positive reactions 163
Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α. 163
Collagen and elastin in scleroderma 160
Development of psoriasis during dialysis 160
Skin cancer in heart transplant recipients: frequency and risk factor analysis 159
The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris. 158
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare Registry 158
Squamous cell carcinoma 157
Red blood cell sodium and potassium fluxes in psoriatic patients 157
The epidemiology of atopic dermatitis in Italian schoolchildren 157
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients 157
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy 157
Familial multiple pigmented naevi and sensorineural deafness. A new autosomal dominant syndrome? 155
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT). 155
Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin-producing cells 155
Ultrastructural and biochemical studies on a case of elastosis perforans serpiginosa 154
EFFECTS OF COMPLEMENT INACTIVATION AND IGG DEPLETION ON SKIN REACTIVITY TO AUTOLOGOUS SERUM IN CHRONIC IDIOPATHIC URTICARIA 154
Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs" 154
CONTACT URTICARIA SYNDROME FROM CONSTITUENTS OF BALSAM OF PERU AND FRAGRANCE MIX IN A PATIENT WITH CHRONIC URTICARIA. 152
Contact sensitization in very young children. 152
Cutaneous viral infections in organ transplant patients 151
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. 151
Altered phosphorylation of erythrocyte membrane proteins in psoriasis 150
Quality of Life Assessment of Patients with Scalp Dermatitis Using the Italian Version of the Scalpdex. 150
Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma 150
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 150
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis. 148
Nickel, cobalt and chromate sensitization and occupation. 148
Etanercept provides a more physiological approach in the treatment of psoriasis. 148
Allergic contact sensitivity in elderly patients 148
[Pseudo-porphyria cutanea tarda in patients with chronic renal insufficienty and in patients with renal transplants] 147
Monoclonal gammopathy in heart transplantation: clinical significance and risk factors 147
Prevalence of metabolic syndrome in patients with psoriasis 146
Effect of ofloxacin on Treponema pallidum in incubating experimental syphilis 146
Totale 18.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.285
article - articoli 92.380
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 612
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.974
Totale 191.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.588 0 345 308 248 122 118 109 297 157 42 319 523
2022/20231.911 511 125 36 192 383 231 3 112 210 8 77 23
2023/2024671 51 93 82 58 33 24 21 18 26 19 157 89
2024/20253.752 26 267 168 104 540 55 145 424 334 137 580 972
2025/202615.461 404 1.448 2.542 2.677 1.264 756 1.639 1.406 1.654 783 557 331
2026/2027731 470 261 0 0 0 0 0 0 0 0 0 0
Totale 34.587